Mustang Bio(MBIO)
$0.46+0.04 (+8.67%)
MBIO
Mustang Bio stock drug pipeline
$0.46
At close:+0.04 (+8.67%)
Want to see MBIO full AI Analyst Report?
Mustang Bio (MBIO) Drug Pipeline
1,601 Followers
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Mb-106 | Small Lymphocytic Lymphoma, Relapsed, Waldenstrom's Macroglobulinemia Recurrent, Follicular B-Cell Non-Hodgkin's Lymphoma, B-Cell Lymphoma Refractory, Mantle Cell Lymphoma Recurrent, Waldenstrom's Macroglobulinemia Refractory, Mantle Cell Lymphoma Refractory, Chronic Lymphoid Leukemia In Relapse | phase1AndPhase2 | Terminated | Study to Assess Safety, Tolerability and Efficacy of MB-106 in Patients With Relapsed or Refractory B-Cell NHL or CLL | Apr 14, 2022 | ― |
| Cyclophosphamide, Fludarabine, Mb-102 | Blastic Plasmacytoid Dendritic Cell Neoplasm (Bpdcn) | phase1AndPhase2 | Terminated | Trial to Evaluate the Safety and Efficacy of MB-102 in Patients With BPDCN. | Sep 25, 2019 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Mb-106 | phase1AndPhase2 | Small Lymphocytic Lymphoma, Relapsed, Waldenstrom's Macroglobulinemia Recurrent, Follicular B-Cell Non-Hodgkin's Lymphoma, B-Cell Lymphoma Refractory, Mantle Cell Lymphoma Recurrent, Waldenstrom's Macroglobulinemia Refractory, Mantle Cell Lymphoma Refractory, Chronic Lymphoid Leukemia In Relapse | Terminated | Study to Assess Safety, Tolerability and Efficacy of MB-106 in Patients With Relapsed or Refractory B-Cell NHL or CLL | Apr 14, 2022 | ― |
| Cyclophosphamide, Fludarabine, Mb-102 | phase1AndPhase2 | Blastic Plasmacytoid Dendritic Cell Neoplasm (Bpdcn) | Terminated | Trial to Evaluate the Safety and Efficacy of MB-102 in Patients With BPDCN. | Sep 25, 2019 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Mustang Bio (MBIO) have in its pipeline
Mustang Bio MBIO is currently developing the following drugs: Mb-106, Cyclophosphamide, Fludarabine, Mb-102. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
